Trial
NCT02568111
Brimonidine Tartrate for the Treatment of Injection Related Erythema
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Biogen
Collaborators
—
Condition
Relapsing-Remitting Multiple Sclerosis (RRMS)
Intervention
peginterferon beta-1a
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-04-25